Terpenes are lipophilic: they dissolve in fats and oils, not water. This single property shapes almost everything about how they're formulated and consumed. It means they need fat-based carriers for oral applications, oil-based carriers for topicals, and can be volatilized for inhalation precisely because their chemical structure makes them want to evaporate. Every consumption method is, at its core, a solution to the fat-solubility constraint.
Inhalation: the fastest path
Aromatherapy and vaporization deliver terpenes through the respiratory tract. Inhaled terpenes cross from the alveoli into systemic circulation rapidly; peak blood concentrations can be achieved in minutes. The olfactory pathway is separately significant: terpenes detected by olfactory receptors in the nasal cavity trigger neural signals that reach the limbic system (the brain's emotional and memory center) before systemic circulation. This dual pathway, respiratory and olfactory simultaneously, is why inhaled terpenes produce some of their most pronounced subjective effects. For vape cartridge applications, terpene percentage (typically 5 to 15% by weight) and the vaporization temperature of the device both influence the actual terpene content reaching the user.
Inhaled, topical, and oral routes create fundamentally different experiences from the same terpene compound. Inhaled limonene reaches the bloodstream rapidly and triggers olfactory signaling simultaneously. Topically applied limonene targets local tissue and absorbs slowly. Orally consumed limonene undergoes liver metabolism before reaching systemic circulation. Same molecule, three different pharmacokinetic profiles.
Topical: localized delivery
Carrier oil selection is the primary variable in topical terpene formulation. Lighter oils (jojoba, fractionated coconut) absorb quickly and are better for facial applications. Heavier oils (avocado, sweet almond) absorb more slowly and are better for body applications where extended contact time is desired. Terpene concentration for topical use typically runs 1 to 5% by weight, enough to be therapeutic without causing skin irritation from concentrated monoterpenes, which can be harsh at high doses. The skin barrier limits systemic absorption; topical terpenes primarily act on local tissue rather than entering circulation at meaningful concentrations.
Terpene selection also shapes penetration depth. Limonene is a documented percutaneous penetration enhancer: it transiently disrupts the intercellular lipid arrangement of the stratum corneum, creating a pathway for co-applied actives to reach viable skin layers more efficiently. This makes limonene-containing topical formulas useful not just for limonene's own antimicrobial and brightening properties, but for improving the delivery of every other active in the preparation. For formulators, carrier-oil choice and terpene profile work together as a single delivery system.
Oral consumption: first-pass metabolism
Oral terpene applications, infused oils, capsules, food-grade terpene products, require emulsification to achieve any meaningful bioavailability, since terpenes don't disperse in water-based digestive fluids. Fat-based carriers (MCT oil, olive oil) improve absorption. After oral ingestion, terpenes are absorbed through the intestinal wall and enter the portal circulation, passing through the liver before reaching systemic circulation. Hepatic first-pass metabolism can significantly alter the terpene profile, converting some compounds and reducing overall concentration. Onset is slower (30 to 90 minutes) and effects are more diffuse compared to inhalation.
The complete dose-by-method reference table, exact concentration ranges, carrier-oil pairings, and onset-timing curves for inhalation, topical, and oral routes, is in Chapter 7 of the printed book.